Cargando…
Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators
The psoralen-related compound, 4,6,4′-trimethylangelicin (TMA) potentiates the cAMP/PKA-dependent activation of WT-CFTR and rescues F508del-CFTR-dependent chloride secretion in both primary and secondary airway cells homozygous for the F508del mutation. We recently demonstrated that TMA, like lumaca...
Autores principales: | Laselva, Onofrio, Marzaro, Giovanni, Vaccarin, Christian, Lampronti, Ilaria, Tamanini, Anna, Lippi, Giuseppe, Gambari, Roberto, Cabrini, Giulio, Bear, Christine E., Chilin, Adriana, Dechecchi, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039571/ https://www.ncbi.nlm.nih.gov/pubmed/30022950 http://dx.doi.org/10.3389/fphar.2018.00719 |
Ejemplares similares
-
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening
por: Vaccarin, Christian, et al.
Publicado: (2022) -
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1
por: Tamanini, Anna, et al.
Publicado: (2021) -
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis
por: Franceschinis, Erica, et al.
Publicado: (2022) -
New TMA (4,6,4′-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease
por: Tupini, Chiara, et al.
Publicado: (2022) -
β-Sitosterol Reduces the Expression of Chemotactic Cytokine Genes in Cystic Fibrosis Bronchial Epithelial Cells
por: Lampronti, Ilaria, et al.
Publicado: (2017)